ATE347370T1 - Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media - Google Patents

Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media

Info

Publication number
ATE347370T1
ATE347370T1 AT03745048T AT03745048T ATE347370T1 AT E347370 T1 ATE347370 T1 AT E347370T1 AT 03745048 T AT03745048 T AT 03745048T AT 03745048 T AT03745048 T AT 03745048T AT E347370 T1 ATE347370 T1 AT E347370T1
Authority
AT
Austria
Prior art keywords
hydrogen peroxide
otitis media
producing enzyme
peroxide producing
treat otitis
Prior art date
Application number
AT03745048T
Other languages
English (en)
Inventor
Krister Tano
Original Assignee
Krister Tano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krister Tano filed Critical Krister Tano
Application granted granted Critical
Publication of ATE347370T1 publication Critical patent/ATE347370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01001—NADH peroxidase (1.11.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03745048T 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media ATE347370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Publications (1)

Publication Number Publication Date
ATE347370T1 true ATE347370T1 (de) 2006-12-15

Family

ID=20287356

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745048T ATE347370T1 (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media

Country Status (8)

Country Link
US (1) US20050238635A1 (de)
EP (1) EP1490096B1 (de)
AT (1) ATE347370T1 (de)
AU (1) AU2003215987A1 (de)
DE (1) DE60310212T2 (de)
ES (1) ES2277641T3 (de)
SE (1) SE0200876L (de)
WO (1) WO2003080109A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
PL2276505T3 (pl) * 2008-03-20 2014-01-31 Karobio Ab Sprej do nosa lub krople do nosa do leczenia przeziębienia
CA2947390C (en) 2014-04-30 2022-10-18 Matoke Holdings Limited Antimicrobial compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
WO1992014484A1 (en) * 1991-02-21 1992-09-03 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
SE506529C2 (sv) * 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9708641D0 (en) * 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats

Also Published As

Publication number Publication date
US20050238635A1 (en) 2005-10-27
DE60310212T2 (de) 2007-10-11
ES2277641T3 (es) 2007-07-16
EP1490096B1 (de) 2006-12-06
SE0200876D0 (sv) 2002-03-22
DE60310212D1 (de) 2007-01-18
EP1490096A1 (de) 2004-12-29
SE0200876L (sv) 2003-09-23
WO2003080109A1 (en) 2003-10-02
AU2003215987A1 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
ATE473010T1 (de) Enzyme für pharmazeutische anwendung
HK1071687A1 (en) Pharmaceutical preparation and method of treatmentof human malignancies with arginine deprivation
AU2002236795A1 (en) Compositions and method of tissue superoxygenation
DE60115842D1 (de) Ventilanordnung
WO2006122249A3 (en) Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
DE50014190D1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
EP2099466A4 (de) Verwendung von hydrolytischen und oxidativen enzymen zur auflösung von biofimen in ohren
WO2002008404A3 (en) Production of lysosomal enzymes in plants by transient expression
WO2003024386A3 (en) Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
WO2005112987A3 (en) Method of preparation and use of fibrinolytic enzymes in the treatment of disease
AU8647101A (en) Compounds having activity as inhibitors of cytochrome p450rai
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
WO2008049058A3 (en) Cln2 treatment of alzheimer's disease
PT1451302E (pt) Folhas reconstituídas in vitro de epitélio corneal humano e método de produção das mesmas
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE347370T1 (de) Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media
WO2007084231A3 (en) Treatment of inflammation and organ dysfunction
NO955258L (no) Medisinsk anvendelse av enzymer
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
WO2022092907A3 (ko) 다부위에 적용가능한 플라즈마 치료기
DE50103012D1 (de) Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
EP1567166A4 (de) Superoxid-dismutase-mimika zur behandlungvon augenstörungen und erkrankungen
EP1610814B8 (de) Therapeutische zubereitung für autoimmune erkrankungen
BR0009636A (pt) Preparação de procarboxipeptidase b pancreática, formas iso e muteìnas das mesmas e seu emprego

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties